Magnesium Development Company Gains Breakthrough Device Designation

By Julie A. Vetalice

Magnesium Development Company Gains Breakthrough Device Designation

Magnesium Development Company's HC Screw received FDA's Breakthrough Device designation.

MDC is developing implants utilizing BioMg 250, a patented alloy composition that contains a unique blend of Magnesium and other elements, all of which are essential for healthy bone formation. Notably, MDC's proprietary alloy does not make use of rare earth elements, and accomplishes the objectives for the material technology through a combination of alloying and mechanical formation processes.

The alloy's radiolucency is similar to cortical bone and does not produce imaging artifacts that are common with other metallic implants.

The company's targeted devices may include devices for repair and reconstruction of foot and ankle conditions, as well as addressing sports medicine applications.

Source: Magnesium Development Company

Product Labels: Traditional Soft Tissue Repair

Tags: Regulatory